Skip to main content
MVIS
NASDAQ Manufacturing

Shareholders to Vote on Reverse Split with Reduced Authorized Shares and Convertible Note Issuance

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Scientific Instrument Stocks · Technology
Sentiment info
Neutral
Importance info
8
Price
$0.36
Mkt Cap
$119.448M
52W Low
$0.341
52W High
$1.73
52W Position info
5.5% above low
Off High info
79% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

MVIS is trading near its 52-week low of $0.341 (5.5% above the low).

Summary

MicroVision filed a definitive proxy statement for its annual meeting, seeking shareholder approval for a reverse stock split with a significant reduction in authorized shares, and the issuance of shares for convertible notes to manage debt and avoid cash payments.


Key Events · Corporate Governance and Compliance · MVIS

  • Reverse Stock Split Proposed

    Shareholders will vote on a reverse stock split at a ratio between 1-for-5 and 1-for-15 to regain compliance with Nasdaq's $1.00 minimum bid price requirement by July 13, 2026.

  • Authorized Shares Significantly Reduced

    In response to shareholder feedback, the Board proposes to simultaneously reduce the total authorized shares from 510 million to 150 million if the reverse split is approved, limiting future dilution capacity.

  • Convertible Note Share Issuance Approval

    Shareholders will vote to approve the issuance of shares for $43 million in 2026 Convertible Notes, which is critical to allow the company to settle obligations with equity instead of cash, preserving liquidity.

  • High Potential Dilution from Notes

    The approval for convertible notes could result in the issuance of up to 61.3 million shares, representing a substantial potential dilution of existing shareholders.


Analysis · MVIS · Manufacturing

MicroVision is seeking shareholder approval for critical measures to address its Nasdaq listing compliance and manage debt obligations. The proposed reverse stock split is necessary to meet the $1.00 minimum bid price requirement and avoid delisting. Crucially, the Board has modified this proposal to simultaneously reduce authorized shares from 510 million to 150 million, directly responding to shareholder concerns about excessive future dilution. Additionally, approval is sought for the issuance of shares related to $43 million in convertible notes, which is vital to prevent substantial cash payments that would further strain the company's liquidity. While these actions are dilutive and highlight financial challenges, they are presented as necessary steps to maintain market listing and preserve cash for strategic execution.

At the time of this filing, MVIS was trading at $0.36 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $119.4M. The 52-week trading range was $0.34 to $1.73. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

MVIS - Latest Insights

MVIS
Jul 22, 2026, 9:21 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $0.298
Real-time Price: $0.2582 info
Change: Reverse Stock Split info
Market Cap: $88.158M info
MVIS
Jul 22, 2026, 9:17 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.310
Real-time Price: $0.2582 info
Change: Reverse Stock Split info
Market Cap: $88.158M info
MVIS
Jul 13, 2026, 4:43 PM EDT
Filing Type: S-3
Importance Score:
8
Price at Filing: $0.384
Real-time Price: $0.2582 info
Change: Reverse Stock Split info
Market Cap: $88.158M info
MVIS
Jul 07, 2026, 9:16 AM EDT
Filing Type: DEFA14A
Importance Score:
7
Price at Filing: $0.3578
Real-time Price: $0.2582 info
Change: Reverse Stock Split info
Market Cap: $88.158M info
MVIS
Jul 07, 2026, 9:15 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.3578
Real-time Price: $0.2582 info
Change: Reverse Stock Split info
Market Cap: $88.158M info